首页 > 最新文献

Ambulatory surgery: hospital-replacing technologies最新文献

英文 中文
Aescusan: pharmacology, pharmacokinetics and therapeutic characteristics 七叶参:药理学、药代动力学和治疗特性
Pub Date : 2019-04-14 DOI: 10.21518/1995-1477-2019-1-2-19-25
V. Bogachev, B. Boldin, O. Dzhenina
1 Федеральное государственное бюджетное образовательное учреждение высшего образования «Российский национальный исследовательский медицинский университет имени Н.И. Пирогова» Министерства здравоохранения Российской Федерации: 117997, Россия, г. Москва, ул. Островитянова, д. 1 2 Общество с ограниченной ответственностью «Первый флебологический центр»: 117447, Россия, г. Москва, ул. Дмитрия Ульянова, д. 31
俄罗斯联邦高等教育国家预算高等教育机构“俄罗斯国家卫生研究院n.i. pirogova”:俄罗斯联邦卫生部117997,俄罗斯,莫斯科,乌尔。岛上,d . 12有限责任协会“第一静脉科学中心”:俄罗斯,莫斯科,乌尔。德米特里·乌里亚诺夫,d。31
{"title":"Aescusan: pharmacology, pharmacokinetics and therapeutic characteristics","authors":"V. Bogachev, B. Boldin, O. Dzhenina","doi":"10.21518/1995-1477-2019-1-2-19-25","DOIUrl":"https://doi.org/10.21518/1995-1477-2019-1-2-19-25","url":null,"abstract":"1 Федеральное государственное бюджетное образовательное учреждение высшего образования «Российский национальный исследовательский медицинский университет имени Н.И. Пирогова» Министерства здравоохранения Российской Федерации: 117997, Россия, г. Москва, ул. Островитянова, д. 1 2 Общество с ограниченной ответственностью «Первый флебологический центр»: 117447, Россия, г. Москва, ул. Дмитрия Ульянова, д. 31","PeriodicalId":7496,"journal":{"name":"Ambulatory surgery: hospital-replacing technologies","volume":"37 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74924567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Analysis of a clinical case of a patient with a lymphedema of the right lower limb 右下肢淋巴水肿1例临床分析
Pub Date : 2019-04-14 DOI: 10.21518/1995-1477-2019-1-2-132-138
I. Makarov, N. Makarova
This clinical review describes the patient’s history of a third degree lymphedema of the right lower extremity, who underwent 33 surgical interventions in the form of lipodermatofasciectomy, complicated by frequent recurrent episodes of erysipelas. The article describes the tactics of treatment and the specifics of the selection of knitwear for such a patient.
本临床综述描述了患者右下肢三度淋巴水肿的病史,该患者接受了33次脂肪皮筋膜切除术的手术干预,并伴有丹毒的频繁复发。文章描述了治疗的策略和具体的选择针织品为这样的病人。
{"title":"Analysis of a clinical case of a patient with a lymphedema of the right lower limb","authors":"I. Makarov, N. Makarova","doi":"10.21518/1995-1477-2019-1-2-132-138","DOIUrl":"https://doi.org/10.21518/1995-1477-2019-1-2-132-138","url":null,"abstract":"This clinical review describes the patient’s history of a third degree lymphedema of the right lower extremity, who underwent 33 surgical interventions in the form of lipodermatofasciectomy, complicated by frequent recurrent episodes of erysipelas. The article describes the tactics of treatment and the specifics of the selection of knitwear for such a patient.","PeriodicalId":7496,"journal":{"name":"Ambulatory surgery: hospital-replacing technologies","volume":"59 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83689101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The experience of application of antiscar combined agent with boswellic and hyaluronic acids and cepalin in patients with scars at early stages of their development 乳香酸、透明质酸及头孢菌素联合抗疤痕剂在早期瘢痕患者中的应用体会
Pub Date : 2019-04-14 DOI: 10.21518/1995-1477-2019-1-2-140-145
П М Лаврешин, O. V. Vladimirova, P. M. Lavreshin, Sergey V. Minayev, Vladimir I. Vladimirov
The article describes the experience of application of the combined antiscar agent containing boswellic acid, cepalin, hyaluronic acid and allantoin with the subsequent application of the prolonged action pressing patch with the matrix of active release of cepalin and allantoin at the early stages of formation and maturation of scars in the patients with postoperative, post-burn scars and traces after cosmetic manipulations in the form of persistent skin redness.  A comparison of the efficacy of two therapy schemes for 43 patients aged 18 to 45 in two groups was shown. When evaluating the effectiveness of the therapy by analyzing the data of evaluation scales, ultrasound, dermatoscopy, a greater  effectiveness of the combined antiscar  agent and pressure  patch in comparison with the use of hydrating agents and silicone patches  was noted.
本文介绍了在疤痕形成和成熟的早期阶段,应用含有乳香酸、cepalin、透明质酸和尿囊素的联合抗疤痕剂,并随后应用以cepalin和尿囊素活性释放为基质的长效加压贴片,治疗术后、烧伤后疤痕和美容手法后皮肤持续红肿的患者。比较两组43例18 ~ 45岁患者两种治疗方案的疗效。通过评估量表、超声、皮镜检查等数据对治疗效果进行评价,发现抗疤痕剂联合压力贴片优于水合剂和硅胶贴片。
{"title":"The experience of application of antiscar combined agent with boswellic and hyaluronic acids and cepalin in patients with scars at early stages of their development","authors":"П М Лаврешин, O. V. Vladimirova, P. M. Lavreshin, Sergey V. Minayev, Vladimir I. Vladimirov","doi":"10.21518/1995-1477-2019-1-2-140-145","DOIUrl":"https://doi.org/10.21518/1995-1477-2019-1-2-140-145","url":null,"abstract":"The article describes the experience of application of the combined antiscar agent containing boswellic acid, cepalin, hyaluronic acid and allantoin with the subsequent application of the prolonged action pressing patch with the matrix of active release of cepalin and allantoin at the early stages of formation and maturation of scars in the patients with postoperative, post-burn scars and traces after cosmetic manipulations in the form of persistent skin redness.  A comparison of the efficacy of two therapy schemes for 43 patients aged 18 to 45 in two groups was shown. When evaluating the effectiveness of the therapy by analyzing the data of evaluation scales, ultrasound, dermatoscopy, a greater  effectiveness of the combined antiscar  agent and pressure  patch in comparison with the use of hydrating agents and silicone patches  was noted.","PeriodicalId":7496,"journal":{"name":"Ambulatory surgery: hospital-replacing technologies","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90845230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
CLaCS – Cryo-Laser and Cryo-Sclerotherapy: the use of a transdermal laser in combination with sclerotherapy for the treatment of reticular varicosity CLaCS -冷冻激光和冷冻硬化疗法:使用透皮激光联合硬化疗法治疗网状静脉曲张
Pub Date : 2019-04-14 DOI: 10.21518/1995-1477-2019-1-2-59-63
M. Parikov
One of the variants of CLaCS therapy is presented the method of treatment of reticular varicosity based on the combined application of injectable sclerotherapy and transdermal neodymium laser in combination with skin cooling. This CLaCS variant is the most understandable, logical and easy to use.
本文提出了一种基于注射硬化疗法和透皮钕激光联合皮肤冷却治疗网状静脉曲张的方法。这个CLaCS变体是最容易理解、最符合逻辑、最易于使用的。
{"title":"CLaCS – Cryo-Laser and Cryo-Sclerotherapy: the use of a transdermal laser in combination with sclerotherapy for the treatment of reticular varicosity","authors":"M. Parikov","doi":"10.21518/1995-1477-2019-1-2-59-63","DOIUrl":"https://doi.org/10.21518/1995-1477-2019-1-2-59-63","url":null,"abstract":"One of the variants of CLaCS therapy is presented the method of treatment of reticular varicosity based on the combined application of injectable sclerotherapy and transdermal neodymium laser in combination with skin cooling. This CLaCS variant is the most understandable, logical and easy to use.","PeriodicalId":7496,"journal":{"name":"Ambulatory surgery: hospital-replacing technologies","volume":"60 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85676098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conservative treatment of hemorrhoids: focus on combination tribenoside and lidocaine 痔疮保守治疗:以三苯诺苷联合利多卡因为主
Pub Date : 2019-04-13 DOI: 10.21518/1995-1477-2019-1-2-106-111
Н. Деговцов, D. Trukhan, E. N. Degovtsov, L. Belkina
Hemorrhoidal  disease  has been  known since  ancient  times  and remains  one of the  most  common human  diseases. This review presents the results  of tribenoside and lidocaine combinations used in the conservative therapy of hemorrhoids, which give grounds to  recommend  combination  therapy  with tribenoside and lidocaine  in the  form of rectal  cream and rectal  suppositories as an effective  and safe method of local treatment of hemorrhoids  and moderate  severity in different categories of patients, allowing to achieve rapid clinical improvement.
痔疮病自古为人所知,至今仍是人类最常见的疾病之一。本文综述了三苯醚与利多卡因联合应用于痔疮保守治疗的结果,推荐三苯醚与利多卡因以直肠乳膏和直肠栓剂的形式联合应用,作为一种有效、安全的局部治疗不同类别患者中重度痔疮的方法,使临床得到快速改善。
{"title":"Conservative treatment of hemorrhoids: focus on combination tribenoside and lidocaine","authors":"Н. Деговцов, D. Trukhan, E. N. Degovtsov, L. Belkina","doi":"10.21518/1995-1477-2019-1-2-106-111","DOIUrl":"https://doi.org/10.21518/1995-1477-2019-1-2-106-111","url":null,"abstract":"Hemorrhoidal  disease  has been  known since  ancient  times  and remains  one of the  most  common human  diseases. This review presents the results  of tribenoside and lidocaine combinations used in the conservative therapy of hemorrhoids, which give grounds to  recommend  combination  therapy  with tribenoside and lidocaine  in the  form of rectal  cream and rectal  suppositories as an effective  and safe method of local treatment of hemorrhoids  and moderate  severity in different categories of patients, allowing to achieve rapid clinical improvement.","PeriodicalId":7496,"journal":{"name":"Ambulatory surgery: hospital-replacing technologies","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88481168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The optimal choice of therapy for acute hemorrhoids 治疗急性痔疮的最佳选择
Pub Date : 2019-04-13 DOI: 10.21518/1995-1477-2019-1-2-118-123
M. V. Abritsova
The article  presents the  results  of conservative  therapy  of patients with acute  hemorrhoids, with a 10-day follow-up period,  the purpose of which is to improve the results  of treatment of this category of patients. The patients of Group I received conservative therapy with heparin ointment and Relief Pro® suppositories; Group II received local therapy with heparin ointment without rectal suppositories. Design: a single-center randomized controlled  follow-up study. The study showed the  efficacy of Relief Pro® suppositories in patients with acute  haemorrhoids. The use of suppositories allowed to statistically reliably reduce the level of pain (2.59 ± 0.6 points in Group I versus 3.87 ± 0.7 points in Group II (p < 0.05)) on Day 3 of the therapy, reduce the frequency of blood excretion on Day 2 of the therapy (83% and 32% of patients, respectively (p <0.05)) and eliminate the discomfort in the anus (100% observations in Group I by Day 5 of the therapy and 67% in Group 2 by Day 10 of the therapy (p <0.05)).
本文报道急性痔疮患者保守治疗的结果,随访10天,目的是提高该类患者的治疗效果。第一组患者给予肝素软膏和Relief Pro®栓剂保守治疗;II组局部应用肝素软膏治疗,不使用直肠栓剂。设计:单中心随机对照随访研究。该研究显示了Relief Pro®栓剂对急性痔疮患者的疗效。栓剂的使用允许统计可靠地减少疼痛的水平(2.59±0.6分在我组和3.87±0.7分二组(p < 0.05))在3天的治疗,降低血液的频率排泄2天的治疗(分别为83%和32%的患者(p < 0.05))和消除肛门不适(100%的观察我的第五天治疗组和67%组2第十天的治疗(p < 0.05)。
{"title":"The optimal choice of therapy for acute hemorrhoids","authors":"M. V. Abritsova","doi":"10.21518/1995-1477-2019-1-2-118-123","DOIUrl":"https://doi.org/10.21518/1995-1477-2019-1-2-118-123","url":null,"abstract":"The article  presents the  results  of conservative  therapy  of patients with acute  hemorrhoids, with a 10-day follow-up period,  the purpose of which is to improve the results  of treatment of this category of patients. The patients of Group I received conservative therapy with heparin ointment and Relief Pro® suppositories; Group II received local therapy with heparin ointment without rectal suppositories. Design: a single-center randomized controlled  follow-up study. The study showed the  efficacy of Relief Pro® suppositories in patients with acute  haemorrhoids. The use of suppositories allowed to statistically reliably reduce the level of pain (2.59 ± 0.6 points in Group I versus 3.87 ± 0.7 points in Group II (p < 0.05)) on Day 3 of the therapy, reduce the frequency of blood excretion on Day 2 of the therapy (83% and 32% of patients, respectively (p <0.05)) and eliminate the discomfort in the anus (100% observations in Group I by Day 5 of the therapy and 67% in Group 2 by Day 10 of the therapy (p <0.05)).","PeriodicalId":7496,"journal":{"name":"Ambulatory surgery: hospital-replacing technologies","volume":"84 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80664058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The role of ketorolac in the accelerated rehabilitation program for patients in outpatient surgery 酮罗拉酸在门诊手术患者加速康复计划中的作用
Pub Date : 2019-04-13 DOI: 10.21518/1995-1477-2019-1-2-99-105
B. K. Vandanov, N. N. Lebedev, A. N. Shikhmetov
The paper presents the basic principles of accelerated reabiletacii patient in the practice of ambulatory surgery. Pathophysiological mechanisms  revealed  organism  response   to  surgical  trauma.   Pain,  as  a  powerful  trigger  of  surgical  stress  response   due  to neurohumoral, endocrine,  immune,  Hemostatic  and metabolic  mechanisms  largely determines the  results  of surgical  treatment. The most  commonly used  ketorolac  (Ketanov)  having  the  form parenteralnuju. The summary of the  application of both  drug ketorolac  argued with pronounced analgesic effect. Intra-operative use of ketorolac  is justified, as the drug reduces the total dose of anesthetics and Narcotic  analgesics. Improving  the  quality  of postoperative analgesia  has  predetermined creation  protocol analgesia, as basic drugs used non-steroidal anti-inflammatory drugs.
本文介绍了门诊手术中加速病人康复的基本原则。病理生理机制揭示了机体对外科创伤的反应。疼痛作为手术应激反应的有力触发因素,在神经、体液、内分泌、免疫、止血和代谢等机制的共同作用下,很大程度上决定了手术治疗的效果。最常用的酮酸(Ketanov),具有parenteralnuju的形式。总结了两种药物酮咯酸的应用,认为其具有明显的镇痛效果。术中使用酮罗拉酸是合理的,因为该药物减少了麻醉剂和麻醉性镇痛药的总剂量。提高术后镇痛质量有预先制定的镇痛方案,作为基础药物采用非甾体类抗炎药。
{"title":"The role of ketorolac in the accelerated rehabilitation program for patients in outpatient surgery","authors":"B. K. Vandanov, N. N. Lebedev, A. N. Shikhmetov","doi":"10.21518/1995-1477-2019-1-2-99-105","DOIUrl":"https://doi.org/10.21518/1995-1477-2019-1-2-99-105","url":null,"abstract":"The paper presents the basic principles of accelerated reabiletacii patient in the practice of ambulatory surgery. Pathophysiological mechanisms  revealed  organism  response   to  surgical  trauma.   Pain,  as  a  powerful  trigger  of  surgical  stress  response   due  to neurohumoral, endocrine,  immune,  Hemostatic  and metabolic  mechanisms  largely determines the  results  of surgical  treatment. The most  commonly used  ketorolac  (Ketanov)  having  the  form parenteralnuju. The summary of the  application of both  drug ketorolac  argued with pronounced analgesic effect. Intra-operative use of ketorolac  is justified, as the drug reduces the total dose of anesthetics and Narcotic  analgesics. Improving  the  quality  of postoperative analgesia  has  predetermined creation  protocol analgesia, as basic drugs used non-steroidal anti-inflammatory drugs.","PeriodicalId":7496,"journal":{"name":"Ambulatory surgery: hospital-replacing technologies","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72698403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review of modern phlebotrophic preparations based on flavonoids as perspective endothelioprotectors in the treatment of chronic diseases of the veins 以黄酮类化合物为基础的现代血管营养制剂治疗慢性静脉疾病的研究进展
Pub Date : 2019-04-12 DOI: 10.21518/1995-1477-2019-1-2-27-33
A. Voronkov, O. Gamzeleva
This review examines the development of endothelial dysfunction in chronic venous diseases  (СVD), the multifactority of this process. The important role of the nitric oxide system as a universal modulator of various biochemical reactions and realization of many important physiological  functions is shown. The need for early pharmacotherapy of phleboprotectors with endothelioprotective activity is discussed  in order to slow the progression  of CVD. Effects of flavonoids as perspective endothelioprotectors on various links in the pathogenesis of endothelial dysfunction are considered. On the example of the micronized purified  flavonoid fraction (MPFF), the effect of flavonoid compounds on endothelial dysfunction in CVD is demonstrated, and the mechanisms of action have been examined in detail. In addition, the pharmacological  effects  of individual components of the MPFF and their synergism in the focus on the effect on endothelial dysfunction are also discussed.  Features  of the micronized form that affect bioavailability and, ultimately, determine the pharmacological  effectiveness of the drug are considered.
本文综述了慢性静脉疾病中内皮功能障碍的发展(СVD),以及这一过程的多因素。一氧化氮系统作为各种生物化学反应的通用调节剂和许多重要生理功能的实现的重要作用。为了减缓心血管疾病的进展,我们讨论了具有内皮保护活性的静脉保护剂早期药物治疗的必要性。黄酮类化合物作为内皮保护剂在内皮功能障碍发病机制的各个环节中的作用。以微粉纯化类黄酮组分(MPFF)为例,研究了类黄酮化合物对心血管疾病内皮功能障碍的影响,并对其作用机制进行了详细的探讨。此外,还讨论了MPFF各成分的药理作用及其协同作用对内皮功能障碍的影响。考虑了影响生物利用度并最终决定药物药理有效性的微粉形式的特征。
{"title":"Review of modern phlebotrophic preparations based on flavonoids as perspective endothelioprotectors in the treatment of chronic diseases of the veins","authors":"A. Voronkov, O. Gamzeleva","doi":"10.21518/1995-1477-2019-1-2-27-33","DOIUrl":"https://doi.org/10.21518/1995-1477-2019-1-2-27-33","url":null,"abstract":"This review examines the development of endothelial dysfunction in chronic venous diseases  (СVD), the multifactority of this process. The important role of the nitric oxide system as a universal modulator of various biochemical reactions and realization of many important physiological  functions is shown. The need for early pharmacotherapy of phleboprotectors with endothelioprotective activity is discussed  in order to slow the progression  of CVD. Effects of flavonoids as perspective endothelioprotectors on various links in the pathogenesis of endothelial dysfunction are considered. On the example of the micronized purified  flavonoid fraction (MPFF), the effect of flavonoid compounds on endothelial dysfunction in CVD is demonstrated, and the mechanisms of action have been examined in detail. In addition, the pharmacological  effects  of individual components of the MPFF and their synergism in the focus on the effect on endothelial dysfunction are also discussed.  Features  of the micronized form that affect bioavailability and, ultimately, determine the pharmacological  effectiveness of the drug are considered.","PeriodicalId":7496,"journal":{"name":"Ambulatory surgery: hospital-replacing technologies","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76668832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Possibilities of treatment of symptoms of chronic diseases of lower limbs veins 下肢静脉慢性疾病症状治疗的可能性
Pub Date : 2019-01-01 DOI: 10.21518/1995-1477-2019-1-2-34-37
M. N. Kudykin
The review presents literature on the epidemiology  of chronic venous diseases  (CVD) and chronic venous insufficiency (CVI). The main approaches to the  choice of conservative  therapy  for CVD and CVI are presented. The rationality of symptomatic treatment of this category of patients is justified. Data on clinical effects  and mechanisms  of their realization in the preparation of calcium dobesilate are given. The results  of preclinical and clinical studies to assess the efficacy and safety of calcium dobesilate in relation to the  symptomatic treatment of CVD and CVI are presented. On the  basis  of the  analysis  of literary  sources  the  conclusion  on expediency of wide application of calcium dobesilate in phlebological practice is presented.
本文综述了慢性静脉疾病(CVD)和慢性静脉功能不全(CVI)的流行病学文献。本文介绍了CVD和CVI患者选择保守治疗的主要途径。这类患者对症治疗的合理性是合理的。本文给出了多苯磺酸钙制剂的临床效果及其实现机制的数据。本文介绍了临床前和临床研究的结果,以评估dobesilate钙在CVD和CVI对症治疗中的有效性和安全性。在对文献资料进行分析的基础上,提出了多苯磺酸钙在血液实践中广泛应用的方便性结论。
{"title":"Possibilities of treatment of symptoms of chronic diseases of lower limbs veins","authors":"M. N. Kudykin","doi":"10.21518/1995-1477-2019-1-2-34-37","DOIUrl":"https://doi.org/10.21518/1995-1477-2019-1-2-34-37","url":null,"abstract":"The review presents literature on the epidemiology  of chronic venous diseases  (CVD) and chronic venous insufficiency (CVI). The main approaches to the  choice of conservative  therapy  for CVD and CVI are presented. The rationality of symptomatic treatment of this category of patients is justified. Data on clinical effects  and mechanisms  of their realization in the preparation of calcium dobesilate are given. The results  of preclinical and clinical studies to assess the efficacy and safety of calcium dobesilate in relation to the  symptomatic treatment of CVD and CVI are presented. On the  basis  of the  analysis  of literary  sources  the  conclusion  on expediency of wide application of calcium dobesilate in phlebological practice is presented.","PeriodicalId":7496,"journal":{"name":"Ambulatory surgery: hospital-replacing technologies","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74527850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of chronic venous insufficiency of the lower extremities 下肢慢性静脉功能不全的处理
Pub Date : 2018-12-04 DOI: 10.21518/1995-1477-2018-3-4-36-41
M. N. Kudykin
The article presents up-to-date information about epidemiology, pathogenesis and clinical manifestations of chronic venous diseases and chronic venous insufficiency of the lower extremities. It discusses the mechanism of action of various phlebotrophic drugs intended for the treatment of symptoms of chronic venous diseases and chronic venous insufficiency and describes the advantages of micronized purified flavonoid fraction for the treatment of all clinical classes of chronic venous diseases.
本文介绍了慢性静脉疾病和下肢慢性静脉功能不全的流行病学、发病机制和临床表现的最新信息。它讨论了用于治疗慢性静脉疾病和慢性静脉功能不全症状的各种静脉营养药物的作用机制,并描述了微粉纯化类黄酮提取物在治疗所有临床类别的慢性静脉疾病方面的优势。
{"title":"Management of chronic venous insufficiency of the lower extremities","authors":"M. N. Kudykin","doi":"10.21518/1995-1477-2018-3-4-36-41","DOIUrl":"https://doi.org/10.21518/1995-1477-2018-3-4-36-41","url":null,"abstract":"The article presents up-to-date information about epidemiology, pathogenesis and clinical manifestations of chronic venous diseases and chronic venous insufficiency of the lower extremities. It discusses the mechanism of action of various phlebotrophic drugs intended for the treatment of symptoms of chronic venous diseases and chronic venous insufficiency and describes the advantages of micronized purified flavonoid fraction for the treatment of all clinical classes of chronic venous diseases.","PeriodicalId":7496,"journal":{"name":"Ambulatory surgery: hospital-replacing technologies","volume":"45 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84062842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Ambulatory surgery: hospital-replacing technologies
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1